UNC Health Medication Formulary
Add Formweb to your mobile device
System Formulary Update
Denosumab-bbdz (Jubbonti) 60 mg/mL syringe
December 9, 2025
Situation
Denosumab-bbdz (Jubbonti) 60 mg/mL syringe was approved for addition to the UNC Health system formulary by the Executive Pharmacy and Therapeutics group in November 2025.
Background
The following medication was reviewed: Denosumab-bbdz (Jubbonti) 60 mg/mL syringe
Assessment/Recommendation
Change effective: Tuesday, December 16, 2025
- System P&T voted to include the following product on the UNC Health Medication Formulary: Denosumab-bbdz (Jubbonti) 60 mg/mL syringe